Skip to content
Conditions & Health

Fibrosis

The excessive formation of fibrous connective tissue in an organ, impairing its function. Can affect the liver (cirrhosis), lungs (pulmonary fibrosis), or any injured tissue. Anti-fibrotic peptide research is active.

Frequently Asked Questions

What is Fibrosis?
The excessive formation of fibrous connective tissue in an organ, impairing its function. Can affect the liver (cirrhosis), lungs (pulmonary fibrosis), or any injured tissue. Anti-fibrotic peptide research is active.
Why is Fibrosis important in peptide research?
Understanding fibrosis is important because it represents a health condition where peptide interventions are being actively researched. Knowledge of the underlying pathology helps inform peptide selection and protocol design.

Related Terms

Scar tissue

Dense, fibrous connective tissue that replaces normal tissue after injury. Peptides like BPC-157 and TB-500 may improve scar remodeling by promoting organized collagen deposition and reducing fibrosis.

Inflammation

The body’s immune response to injury, infection, or irritation. Acute inflammation is protective; chronic inflammation drives disease. Many peptides (BPC-157, KPV, LL-37, Thymosin Alpha-1) modulate inflammatory pathways.

MASH

Metabolic dysfunction-associated steatohepatitis (formerly NASH). Inflammatory liver disease with fat accumulation, hepatocyte damage, and fibrosis risk. Survodutide and semaglutide are in trials for MASH treatment.

← Back to full glossary